![](/img/cover-not-exists.png)
Reduction of Risk of Secondary Progressive Multiple Sclerosis Within Two Years of Treatment with Cladribine Tablets: An Analysis of the CLARITY Study
Vermersch, Patrick, Giovannoni, Gavin, Sørensen, Per Soelberg, Rammohan, Kottil, Cook, Stuart, Keller, Birgit, Roy, SanjeevVolume:
37
Journal:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2019.11.077
Date:
January, 2020
File:
PDF, 105 KB
2020